TOXIN PEPTIDE THERAPEUTIC AGENTS
Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | NGUYEN, HUNG Q MARTIN, FRANCIS H SULLIVAN, JOHN K GEGG, COLIN V., JR MCGIVERN, JOSEPH G ARORA KHARE, TARUNA MIRANDA, LESLIE P WALKER, KENNETH W ADLER, BEVERLY S HU, SHAW-FEN SYLVIA |
description | Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2667678A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2667678A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2667678A13</originalsourceid><addsrcrecordid>eNrjZFAI8Y_w9FMIcA0I8XRxVQjxcA1yDHANDfF0VnB0d_ULCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkZmZuZm5haOhsZEKAEAwj8hng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TOXIN PEPTIDE THERAPEUTIC AGENTS</title><source>esp@cenet</source><creator>NGUYEN, HUNG Q ; MARTIN, FRANCIS H ; SULLIVAN, JOHN K ; GEGG, COLIN V., JR ; MCGIVERN, JOSEPH G ; ARORA KHARE, TARUNA ; MIRANDA, LESLIE P ; WALKER, KENNETH W ; ADLER, BEVERLY S ; HU, SHAW-FEN SYLVIA</creator><creatorcontrib>NGUYEN, HUNG Q ; MARTIN, FRANCIS H ; SULLIVAN, JOHN K ; GEGG, COLIN V., JR ; MCGIVERN, JOSEPH G ; ARORA KHARE, TARUNA ; MIRANDA, LESLIE P ; WALKER, KENNETH W ; ADLER, BEVERLY S ; HU, SHAW-FEN SYLVIA</creatorcontrib><description>Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080724&DB=EPODOC&CC=CA&NR=2667678A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080724&DB=EPODOC&CC=CA&NR=2667678A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NGUYEN, HUNG Q</creatorcontrib><creatorcontrib>MARTIN, FRANCIS H</creatorcontrib><creatorcontrib>SULLIVAN, JOHN K</creatorcontrib><creatorcontrib>GEGG, COLIN V., JR</creatorcontrib><creatorcontrib>MCGIVERN, JOSEPH G</creatorcontrib><creatorcontrib>ARORA KHARE, TARUNA</creatorcontrib><creatorcontrib>MIRANDA, LESLIE P</creatorcontrib><creatorcontrib>WALKER, KENNETH W</creatorcontrib><creatorcontrib>ADLER, BEVERLY S</creatorcontrib><creatorcontrib>HU, SHAW-FEN SYLVIA</creatorcontrib><title>TOXIN PEPTIDE THERAPEUTIC AGENTS</title><description>Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAI8Y_w9FMIcA0I8XRxVQjxcA1yDHANDfF0VnB0d_ULCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkZmZuZm5haOhsZEKAEAwj8hng</recordid><startdate>20080724</startdate><enddate>20080724</enddate><creator>NGUYEN, HUNG Q</creator><creator>MARTIN, FRANCIS H</creator><creator>SULLIVAN, JOHN K</creator><creator>GEGG, COLIN V., JR</creator><creator>MCGIVERN, JOSEPH G</creator><creator>ARORA KHARE, TARUNA</creator><creator>MIRANDA, LESLIE P</creator><creator>WALKER, KENNETH W</creator><creator>ADLER, BEVERLY S</creator><creator>HU, SHAW-FEN SYLVIA</creator><scope>EVB</scope></search><sort><creationdate>20080724</creationdate><title>TOXIN PEPTIDE THERAPEUTIC AGENTS</title><author>NGUYEN, HUNG Q ; MARTIN, FRANCIS H ; SULLIVAN, JOHN K ; GEGG, COLIN V., JR ; MCGIVERN, JOSEPH G ; ARORA KHARE, TARUNA ; MIRANDA, LESLIE P ; WALKER, KENNETH W ; ADLER, BEVERLY S ; HU, SHAW-FEN SYLVIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2667678A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2008</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>NGUYEN, HUNG Q</creatorcontrib><creatorcontrib>MARTIN, FRANCIS H</creatorcontrib><creatorcontrib>SULLIVAN, JOHN K</creatorcontrib><creatorcontrib>GEGG, COLIN V., JR</creatorcontrib><creatorcontrib>MCGIVERN, JOSEPH G</creatorcontrib><creatorcontrib>ARORA KHARE, TARUNA</creatorcontrib><creatorcontrib>MIRANDA, LESLIE P</creatorcontrib><creatorcontrib>WALKER, KENNETH W</creatorcontrib><creatorcontrib>ADLER, BEVERLY S</creatorcontrib><creatorcontrib>HU, SHAW-FEN SYLVIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NGUYEN, HUNG Q</au><au>MARTIN, FRANCIS H</au><au>SULLIVAN, JOHN K</au><au>GEGG, COLIN V., JR</au><au>MCGIVERN, JOSEPH G</au><au>ARORA KHARE, TARUNA</au><au>MIRANDA, LESLIE P</au><au>WALKER, KENNETH W</au><au>ADLER, BEVERLY S</au><au>HU, SHAW-FEN SYLVIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TOXIN PEPTIDE THERAPEUTIC AGENTS</title><date>2008-07-24</date><risdate>2008</risdate><abstract>Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2667678A1 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | TOXIN PEPTIDE THERAPEUTIC AGENTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A09%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NGUYEN,%20HUNG%20Q&rft.date=2008-07-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2667678A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |